He was appointed Director of the Department for the Evaluation of Medicinal Products at the Agence Française de Sécurité Sanitaire des Produits de Santé in 1993 and, in the same year, elected as Chairman of the former Committee for Proprietary Medicinal Products attached to the European Commission.